Trial Profile
Combination pharmacotherapy for the management of pain in fibromyalgia: a double-blind, randomised, placebo-controlled, four-period crossover trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2022
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Pregabalin (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- 08 Mar 2011 New trial record